Login / Signup

Impact of COVID-19 on Patient-Initiated Discontinuation of Omalizumab in Two Academic Hospital Clinics at the University of Toronto.

Jason Ho Seung KimJorge-Ryan GeorgakopoulosJensen Yeung
Published in: Journal of cutaneous medicine and surgery (2020)
Keyphrases
  • coronavirus disease
  • sars cov
  • primary care
  • case report
  • healthcare
  • acute care
  • adverse drug
  • emergency department